Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated:  3/21/2018
mi
from
Manchester, NH
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated: 3/21/2018
Mental Health Center of Greater Manchester
mi
from
Manchester, NH
Click here to add this to my saved trials
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated:  3/21/2018
mi
from
Nashua, NH
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated: 3/21/2018
Center for Psychiatric Advancement
mi
from
Nashua, NH
Click here to add this to my saved trials
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated:  3/21/2018
mi
from
Columbia, SC
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated: 3/21/2018
University of South Carolina
mi
from
Columbia, SC
Click here to add this to my saved trials
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated:  3/21/2018
mi
from
White River Junction, VT
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated: 3/21/2018
White River Junction Veterans Admininistration Medical Center
mi
from
White River Junction, VT
Click here to add this to my saved trials
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated:  3/21/2018
mi
from
Saint Louis, MO
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated: 3/21/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
mi
from
Miami, FL
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
University of Miami Medical Center
mi
from
Miami, FL
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
mi
from
Baltimore, MD
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
mi
from
Englewood, NJ
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
mi
from
Cleveland, OH
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
mi
from
College Park, MD
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
The University of Maryland
mi
from
College Park, MD
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
mi
from
Rochester, MN
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
mi
from
Saint Louis, MO
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
St. Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
mi
from
New York, NY
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
mi
from
Chapel Hill, NC
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
mi
from
Columbus, OH
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Brain Mechanisms of Human Motivation
Multi Level Analysis of Positive Valence Systems Across Mood Disorders
Status: Enrolling
Updated:  3/22/2018
mi
from
Belmont, MA
Brain Mechanisms of Human Motivation
Multi Level Analysis of Positive Valence Systems Across Mood Disorders
Status: Enrolling
Updated: 3/22/2018
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
CBT for Aggression in Veterans
Group Cognitive Behavioral Therapy for Anger and Aggression in Veterans With PTSD
Status: Enrolling
Updated:  3/22/2018
mi
from
Durham, NC
CBT for Aggression in Veterans
Group Cognitive Behavioral Therapy for Anger and Aggression in Veterans With PTSD
Status: Enrolling
Updated: 3/22/2018
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Click here to add this to my saved trials
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Status: Enrolling
Updated:  3/22/2018
mi
from
New York, NY
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Status: Enrolling
Updated: 3/22/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Status: Enrolling
Updated:  3/22/2018
mi
from
Calgary,
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Status: Enrolling
Updated: 3/22/2018
Tom Baker Cancer Centre
mi
from
Calgary,
Click here to add this to my saved trials
It's Your Game: An Innovative Approach to Preventing Teen Dating Violence
It's Your Game: An Innovative Approach to Preventing Teen Dating Violence
Status: Enrolling
Updated:  3/22/2018
mi
from
Houston, TX
It's Your Game: An Innovative Approach to Preventing Teen Dating Violence
It's Your Game: An Innovative Approach to Preventing Teen Dating Violence
Status: Enrolling
Updated: 3/22/2018
Melissa Fleschler Peskin
mi
from
Houston, TX
Click here to add this to my saved trials
Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine Dependence
Contingency Management Plus Levodopa/Carbidopa for Treatment of Cocaine Dependence
Status: Enrolling
Updated:  3/23/2018
mi
from
Houston, TX
Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine Dependence
Contingency Management Plus Levodopa/Carbidopa for Treatment of Cocaine Dependence
Status: Enrolling
Updated: 3/23/2018
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Cognitive Remediation for Cocaine Dependence
Cognitive-enhancing DA Medications for Cocaine Dependence
Status: Enrolling
Updated:  3/23/2018
mi
from
Houston, TX
Cognitive Remediation for Cocaine Dependence
Cognitive-enhancing DA Medications for Cocaine Dependence
Status: Enrolling
Updated: 3/23/2018
Behavioral and Biomedical Sciences Building
mi
from
Houston, TX
Click here to add this to my saved trials
Treatment of Anxiety and Anorexia Nervosa in Adolescents
Treatment of Anxiety and Anorexia Nervosa in Adolescents
Status: Enrolling
Updated:  3/23/2018
mi
from
Columbus, OH
Treatment of Anxiety and Anorexia Nervosa in Adolescents
Treatment of Anxiety and Anorexia Nervosa in Adolescents
Status: Enrolling
Updated: 3/23/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Online Cognitive Behavioral Therapy for Bulimia Nervosa
Optimizing Technology in the Treatment of Bulimia Nervosa
Status: Enrolling
Updated:  3/26/2018
mi
from
Chapel Hill, NC
Online Cognitive Behavioral Therapy for Bulimia Nervosa
Optimizing Technology in the Treatment of Bulimia Nervosa
Status: Enrolling
Updated: 3/26/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Online Cognitive Behavioral Therapy for Bulimia Nervosa
Optimizing Technology in the Treatment of Bulimia Nervosa
Status: Enrolling
Updated:  3/26/2018
mi
from
Pittsburgh, PA
Online Cognitive Behavioral Therapy for Bulimia Nervosa
Optimizing Technology in the Treatment of Bulimia Nervosa
Status: Enrolling
Updated: 3/26/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Indianapolis, IN
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Seattle, WA
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Spring Valley, CA
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Spring Valley, CA
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Gainesville, FL
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Orlando, FL
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
University Park, FL
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
University Park, FL
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Smyrna, GA
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Smyrna, GA
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Libertyville, IL
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Libertyville, IL
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Rochester Hills, MI
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Omaha, NE
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Las Vegas, NV
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Philadelphia, PA
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Memphis, TN
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Lake Jackson, TX
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Lubbock, TX
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Lubbock, TX
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Herndon, VA
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Herndon, VA
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Kelowna,
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Kelowna,
Click here to add this to my saved trials
A Double Blind Clinical Trial of DCS for Food Anxiety
A Double Blind Clinical Trial of DCS for Food Anxiety for Patients With Anorexia and Bulimia Nervosa
Status: Enrolling
Updated:  3/26/2018
mi
from
Saint Louis, MO
A Double Blind Clinical Trial of DCS for Food Anxiety
A Double Blind Clinical Trial of DCS for Food Anxiety for Patients With Anorexia and Bulimia Nervosa
Status: Enrolling
Updated: 3/26/2018
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder
The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder
Status: Enrolling
Updated:  3/26/2018
mi
from
Loma Linda, CA
The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder
The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 3/26/2018
Loma Linda University Health
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Testing an Alternative Therapy for Bulimia Nervosa
Integrative Cognitive Affective Therapy for Bulimia Nervosa (ICAT)
Status: Enrolling
Updated:  3/27/2018
mi
from
Minneapolis, MN
Testing an Alternative Therapy for Bulimia Nervosa
Integrative Cognitive Affective Therapy for Bulimia Nervosa (ICAT)
Status: Enrolling
Updated: 3/27/2018
University of Minnesota Eating Disorders Research Program
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Testing an Alternative Therapy for Bulimia Nervosa
Integrative Cognitive Affective Therapy for Bulimia Nervosa (ICAT)
Status: Enrolling
Updated:  3/27/2018
mi
from
Fargo, ND
Testing an Alternative Therapy for Bulimia Nervosa
Integrative Cognitive Affective Therapy for Bulimia Nervosa (ICAT)
Status: Enrolling
Updated: 3/27/2018
Neuropsychiatric Research Institute
mi
from
Fargo, ND
Click here to add this to my saved trials
Neural and Visual Responses to Light in Bipolar Disorder: A Novel Putative Biomarker
Neural and Visual Responses to Light in Bipolar Disorder: A Novel Putative Biomarker
Status: Enrolling
Updated:  3/27/2018
mi
from
Pittsburgh, PA
Neural and Visual Responses to Light in Bipolar Disorder: A Novel Putative Biomarker
Neural and Visual Responses to Light in Bipolar Disorder: A Novel Putative Biomarker
Status: Enrolling
Updated: 3/27/2018
Western Psychiatric Institute and Clinic
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Integrated Metacognitive Therapy in First Episode Psychosis
An Integrated Metacognitive Approach to Improve Insight and Outcomes in Early Psychosis
Status: Enrolling
Updated:  3/27/2018
mi
from
Indianapolis, IN
Integrated Metacognitive Therapy in First Episode Psychosis
An Integrated Metacognitive Approach to Improve Insight and Outcomes in Early Psychosis
Status: Enrolling
Updated: 3/27/2018
Prevention and Recovery Center for Early Psychosis
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Integrated Metacognitive Therapy in First Episode Psychosis
An Integrated Metacognitive Approach to Improve Insight and Outcomes in Early Psychosis
Status: Enrolling
Updated:  3/27/2018
mi
from
Indianapolis, IN
Integrated Metacognitive Therapy in First Episode Psychosis
An Integrated Metacognitive Approach to Improve Insight and Outcomes in Early Psychosis
Status: Enrolling
Updated: 3/27/2018
Psychosocial Rehabilitation and Recovery Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
Status: Enrolling
Updated:  3/27/2018
mi
from
Bethesda, MD
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
Status: Enrolling
Updated: 3/27/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials